source
- Roivant's mosliciguat shows strong efficacy in Phase 2 PH-ILD trialRoivant's experimental drug mosliciguat achieved strong efficacy signals in a Phase 2 study of pulmonary hypertension associated with interstitial lung disease (PH-ILD). The mid-stage trial met its…
- Midterm races in Iowa, Florida and others could shape US vaccine policyVaccine policy has emerged as a prominent issue in the lead‑up to the November midterms, spurred by the president and health secretary’s skeptical stance. In Iowa, the Republican candidate for gov…